ARCH Venture Partners IX, L.P.'s Net Worth

$660 Million

Estimate Recalculated Feb 20, 2024 09:07PM EST

Who is ARCH Venture Partners IX, L.P.?

ARCH Venture Partners IX, L.P. has an estimated net worth of $660 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Lyell Immunopharma, Inc., Gossamer Bio, Inc., Karuna Therapeutics, Inc., Vir Biotechnology, Inc., and Beam Therapeutics Inc..

SEC CIK

ARCH Venture Partners IX, L.P.'s CIK is 0001723173

Past Insider Trading and Trends

2021 was ARCH Venture Partners IX, L.P.'s most active year for acquiring shares with 43 total transactions. ARCH Venture Partners IX, L.P.'s most active month to acquire stocks was the month of July. 2021 was ARCH Venture Partners IX, L.P.'s most active year for disposing of shares, totalling 48 transactions. ARCH Venture Partners IX, L.P.'s most active month to dispose stocks was the month of January. 2019 saw ARCH Venture Partners IX, L.P. paying a total of $23,200,000.00 for 39,641,007 shares, this is the most they've acquired in one year. In 2021 ARCH Venture Partners IX, L.P. cashed out on 92,612,716 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
36.41M
36.41M
Jun 21
Form 3
0
0
No matching records found

Gossamer Bio, Inc. (GOSS) Snapshot price: $0.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
8.06M
8.06M
Feb 12
Form 3
0
0
No matching records found

Karuna Therapeutics, Inc. (KRTX) Snapshot price: $315.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.85%
-148.74K
2.92M
Apr 13
Form 4
-4.63%
-148.74K
3.07M
Jan 8
Form 4
-4.42%
-148.74K
3.21M
Nov 12
Form 4
+364.09%
3.36M
$16.00
$1,600,000.00
4.29M
Jul 2
Form 3
0
0
No matching records found

Vir Biotechnology, Inc. (VIR) Snapshot price: $8.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.44%
-964.98K
27.09M
Sep 2 - Sep 6
Form 4
-3.22%
-964.99K
28.98M
Aug 30 - Aug 31
Form 4
-3.03%
-964.99K
30.91M
Aug 24 - Aug 25
Form 4
-2.90%
-482.50K
16.18M
Aug 18
Form 4
-2.74%
-1.45M
51.42M
Aug 12 - Aug 16
Form 4
-2.60%
-482.50K
18.11M
Jun 8
Form 4
-2.53%
-482.50K
18.59M
Jun 2
Form 4
-8.13%
-1.69M
19.07M
Dec 20
Form 4
-2.27%
-482.51K
20.76M
Nov 29
Form 4
-2.22%
-482.51K
21.24M
Nov 22
Form 4
-15.44%
-3.97M
21.73M
Jul 1
Form 4
-3.72%
-991.65K
25.69M
Jun 22
Form 4
-1.81%
-991.64K
53.86M
Apr 7 - Apr 8
Form 4
-1.74%
-991.65K
55.85M
Mar 30 - Apr 1
Form 4
+6,350.01%
28.22M
$20.00
$20,000,000.00
28.67M
Oct 16
Form 3
0
0
No matching records found

Beam Therapeutics Inc. (BEAM) Snapshot price: $27.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.24%
-391.95K
5.89M
Jun 30
Form 4
-7.52%
-783.90K
9.64M
Jun 25 - Jun 29
Form 4
-5.32%
-396.63K
7.05M
Mar 31
Form 4
-6.52%
-793.27K
11.37M
Mar 18 - Mar 22
Form 4
8.24M
8.24M
Feb 10
Form 3
0
0
No matching records found